ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
a study on Frontotemporal Lobar Degeneration Progressive Supranuclear Palsy Corticobasal Degeneration Behavioral Variant Frontotemporal Dementia Dementia Frontotemporal Dementia Primary Progressive Aphasia Semantic Variant Primary Progressive Aphasia Progressive Nonfluent Aphasia Amyotropic Lateral Sclerosis (ALS) MAPT Gene Mutation TBK1 Gene Mutation Aphasia
Frontotemporal Lobar Degeneration (FTLD), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD), Behavioral Variant Frontotemporal Dementia (bvFTD), Semantic Variant Primary Progressive Aphasia (svPPA), Nonfluent Variant Primary Progressive Aphasia (nfvPPA), FTD With Amyotrophic Lateral Sclerosis (FTD/ALS), Amyotrophic Lateral Sclerosis, Oligosymptomatic PSP (oPSP), C9orf72, GRN Related Frontotemporal Dementia, MAPT Gene Mutation, TBK1 Gene Mutation, Oligosymptomatic Progressive Supranuclear Palsy, Dementia, Motor Neuron Disease, Aphasia, Frontotemporal Dementia, Primary Progressive Aphasia, Pick Disease of the Brain, Progressive Supranuclear Palsy, Frontotemporal Lobar Degeneration, Corticobasal Degeneration, Sclerosis
Lead Scientists at University of California Health
- Adam Boxer, MD, PhD (ucsf)
Adam L. Boxer, MD, PhD is Endowed Professor in Memory and Aging in the Department of Neurology at the University of California, San Francisco (UCSF). He directs UCSF’s Neurosciences Clinical Research Unit and the Alzheimer’s Disease and Frontotemporal Degeneration (FTD) Clinical Trials Program at the UCSF Memory and Aging Center.
- Howie Rosen, MD (ucsf)
Professor, Neurology, School of Medicine. Authored (or co-authored) 325 research publications